StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
DNLIDenali Therapeutics Inc.
stockpulse.co.kr
Nasdaq
$18.49▲ 0.49%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $2.93BShares out 1.600M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

11
  • 9.9After-hours26.09.10 05:44
    4Ownership#●●●

    Denali Therapeutics Inc.

    Insider Chin Peter Scott of Denali Therapeutics Inc. filed a Form 4 on September 9, 2026, reporting changes in beneficial ownership as of September 4, 2026. This filing is a standard disclosure of insider equity transactions and does not involve any financial changes or new capital raising activities.…more

    $18.49+0.49%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.5Closed26.09.05 09:38
    144Ownership

    Denali Therapeutics Inc.

    Insider Chin Peter Scott of Denali Therapeutics Inc. has filed an SEC Form 144 to report a proposed sale of company shares. This is a standard filing disclosing the insider's plan to dispose of their holdings.…more

    $18.49+0.49%vs prev close
    View filingShare
  • 9.4After-hours26.09.05 06:02
    4Ownership

    Denali Therapeutics Inc.

    Insider Nancy Thornberry of Denali Therapeutics Inc. filed a Form 4 report regarding a change in beneficial ownership of securities as of September 2, 2026.…more

    $18.49+0.49%vs prev close
    View filingShare

10 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 2d agoAfter-hours26.10.23 05:01
    #●●●#●●●

    Denali Therapeutics to Report Q3 2026 Financial Results on Nov 3

    Denali Therapeutics announced that it will release its financial results and business highlights for the third quarter of 2026 on November 3. The company will host a conference call to discuss the quarterly performance and provide a general business update.…more

    $18.49+0.49%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    Read sourceShareGlobeNewswire
  • 7.27After-hours26.07.28 05:01

    ●●●●●●●● ●●●●● ●●●●●●

    데날리 테라퓨틱스가 오는 8월 6일 장 마감 후 2026년 2분기 실적 및 주요 사업 현황을 발표합니다. 이번 컨퍼런스 콜을 통해 회사의 최신 임상 진행 상황과 재무 성과가 공개될 예정입니다.…more

    $18.49+0.49%vs prev close
    Read sourceShareGlobeNewswire

1 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →